In rare move, investment adviser named as defendant in NYU retirement plan case

It's one in a growing list of instances where plan advisers are being named co-defendants alongside their clients

Jan 16, 2018 @ 2:04 pm

By Greg Iacurci

In an unusual turn of events, the investment adviser to New York University's retirement plan has been named as a co-defendant in litigation attacking the plan's allegedly excessive fees.

Plaintiffs contend the adviser, Cammack LaRhette Advisors, provided "imprudent investment advice," which enabled NYU to breach its fiduciary duty to plan participants, according to an amended complaint filed in the lawsuit Sacerdote et al v. New York University. The adviser's involvement suggests more retirement plan advisers could find themselves drawn into similar legal battles.

The NYU case was originally filed in August 2016, one of more than a dozen brought that summer against universities for allegedly excessive retirement plan fees. Those lawsuits were noteworthy because they were the first of their kind to target university 403(b) plans. Fee litigation, which has proliferated since an initial tranche in 2006, had previously focused on private-sector 401(k) plans.

NYU was able to beat back parts of the lawsuit in August, when a judge dismissed some allegations, including that the university erred by including too many investment options in the retirement plan. However, some claims were allowed to move forward.

Plaintiffs, represented by Schlichter, Bogard & Denton, the firm that pioneered 401(k) excessive-fee litigation, filed an amended complaint Jan. 10 that, for the first time in the course of the NYU litigation, named Cammack as a co-defendant.

Such a move is noteworthy because advisers to retirement plans had been noticeably absent from the vast majority of 401(k) litigation in the past, but have begun showing up recently.

"We haven't seen many at all that have named the investment advisory firm as a defendant," said Duane Thompson, senior policy analyst at fi360 Inc., a fiduciary consulting firm. "This is unusual, because plaintiffs [typically only] go after the plan sponsor and/or the plan sponsor's investment committee."

(More: Attorney Jerry Schlichter opens up about 403(b), 401(k) suits)

In one recent example, Cetera Advisor Networks was named as a co-defendant alongside its client, Checksmart, for fiduciary breach. There could be many more similar instances in the future due to the Department of Labor's fiduciary rule, Mr. Thompson said. The regulation converted thousands of advisers serving retirement plans into first-time fiduciaries.

The NYU suit claims Cammack served in a co-fiduciary role alongside the plan sponsor, advising on matters such as the reasonableness of fees in investment options, selection of service providers and performance of investments for the $2 billion NYU School of Medicine Retirement Plan.

Plaintiffs allege Cammack's imprudent advice extends to use of weighted averages provided by Morningstar to benchmark plan fees, not recommending removal of the CREF Stock or TIAA Real Estate Accounts from the retirement plan despite "long histories of dramatic underperformance and exorbitant fees," and failing to account for "float" income when evaluating record-keeper fees.

Cammack spokeswoman Cara McAuley said the firm believes the claims have no merit and will "vigorously defend" against them.

NYU spokesman John Beckman, said, "This seems to be the Schlichter firm's response to our motion to dismiss their lawsuit. Their case is without merit, and their suit has already largely been dismissed. We will continue to press for the dismissal of the suit in its entirety."

Plaintiffs in roughly 10 university lawsuits have been successful in getting at least some claims in university retirement-plan lawsuits to move forward.

"Nearly all of these cases that have been filed still have traction, including the class action against New York University," Mr. Thompson said. "Only one case — against the University of Pennsylvania — has been dismissed in its entirety."

0
Comments

What do you think?

View comments

Recommended for you

RIA Data Center

Use InvestmentNews' RIA Data Center to filter and find key information on over 1,400 fee-only registered investment advisory firms.

Rank RIAs by

Upcoming Event

Nov 13

Conference

Best Practices Workshop

For the sixth year, InvestmentNews will host the Best Practices Workshop & Awards, bringing together the industry’s top-performing and most influential firms in one room for a full-day. This exclusive workshop and awards program for the... Learn more

Featured video

FinTech Forum

Advicent's Stich: What the advice revolution means for financial advisers

We are in the midst of an advice revolution, according to Advicent's Anthony Stich. What does this mean for traditional advisers and how can they remain a step ahead of the competition?

Latest news & opinion

The midterm elections: What's at stake for financial advisers

A shift in control of the House could change the course of important issues, including the SEC advice rule, tax reform and retirement policies.

What to tell your clients after they've won the lottery

The current combined Mega Millions and Powerball jackpots are more than $850 million. What should you tell your clients if they have a winning ticket?

2019 Medicare premiums announced

Slight increase in Part B premium to $135.50 per month is in line with expectations.

7 ways states got tough with unregistered individuals and firms in 2017

Rise in digital currency frauds helped trigger a crackdown by state regulators.

Market slide awakens nervous investors, puts advisers back to work

Some reach out to clients who need hand-holding, while others see decline as opportunity to drum up new business.

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print